Straumann Holding AG : Q1 Very strong start to 2022, strong beat, guidance unchanged
>Strong momentum again in the first quarter - Straumann’s Q1 2022 revenues of CHF 588.9 m (+25.4% y-o-y) was a strong beat of our and consensus’ expectations by 10-11%. Organic growth reached 27.2%, which compares with our 18.9% and consensus’ 18.7%. External growth was 70bp and the forex environment created headwind of 250bp.From a regional perspective, Europe achieved 33% organic growth, North America 20.7% and Asia/Pacific 18.4%, while the highest momentum was...Straumann is engaged in tooth replacement solutions that include dental implants, prosthetics and regenerative products. Co. develops, manufactures and supplies dental implants, instruments, computer-aided design/computer-aided manufacturing prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Co. provides a range of services to dental practitioners, clinics and laboratories. Through a collaboration with its academic partner the International Team for Implantology ( ITI), Co. supports research and offers training and education to dental professionals worldwide.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.